"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Masimo SET ® originated in Founder and CEO Joe Kiani’s desire to find a way to monitor the oxygen saturation of those most precious of patients – neonatal infants – accurately and reliably ...

ECG leads were placed on the infant's chest. Masimo and Nellcor oximeter sensors were randomly allocated to each foot. Measurements were collected for 10mins. Screens from the oximeters and ECG ...

The US Food and Drug Administration (FDA) has granted clearance to health tech company Masimo’s MightySat Medical fingertip pulse oximeter, the first FDA-approved medical fingertip pulse ...

Stork leverages the same Masimo SET ® pulse oximetry technology developed over 35 years ago and is the only device with over-the-counter FDA clearance for use on neonates the day they come home*.

Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.

Another vital part of the kit is a pulse oximeter, which [Aris] uses to make sure he’s getting enough oxygen. His O 2 saturation actually goes up from his baseline when the hood is on and ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...

Masimo SET ® Is the Primary ... of those most precious of patients – neonatal infants – accurately and reliably, even though their frequent movement and poor perfusion stymied traditional pulse ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...